Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering promise for more successful t